The artificial cycle as an effective treatment of persistently retarded endometrium in the luteal phase

Hum Reprod. 1994 Mar;9(3):409-12. doi: 10.1093/oxfordjournals.humrep.a138518.

Abstract

The objective of this study was to examine the results of two hormonal treatment modalities on subjects who had persistently abnormal endometrial development in the luteal phase. A prospective study design was used to investigate 14 women who had persistently retarded endometrium associated with infertility (n = 11) or recurrent miscarriage (n = 3). Treatment A consisted of progesterone supplementation in the form of i.m. progesterone at a daily dose of 25-50 mg starting on day luteinizing hormone (LH) + 1 for 14 days. Treatment B consisted of artificial cycles produced after down-regulation of the hypothalamic-pituitary-ovarian axis with Goserelin (3.6 mg s.c.) followed by the administration of a standard hormone replacement therapy. Endometrial biopsy was taken on day 19 of the artificial cycle or days LH + 5 to +7 in the progesterone supplementation cycle. A histological study was made of the endometrial specimens by standard dating criteria and morphometry. The artificial cycle resulted in normal development in all subjects (n = 11), whereas progesterone supplementation restored normal endometrial development in only seven of 11 (64%) subjects. We conclude that persistently retarded endometrium could be treated more effectively with the artificial cycle than with progesterone supplementation.

MeSH terms

  • Abortion, Habitual / drug therapy
  • Abortion, Habitual / etiology*
  • Abortion, Habitual / physiopathology
  • Adult
  • Endometrium / physiopathology*
  • Female
  • Goserelin / administration & dosage
  • Goserelin / therapeutic use*
  • Humans
  • Infertility, Female / drug therapy
  • Infertility, Female / etiology*
  • Infertility, Female / physiopathology
  • Luteal Phase / physiology*
  • Pregnancy
  • Progesterone / administration & dosage
  • Progesterone / therapeutic use*
  • Prospective Studies

Substances

  • Goserelin
  • Progesterone